Adaptive Biotechnologies Corp (ADPT) insider trading

By person

12 insiders · 37 transactions

81.1×

Chad Robins holds 81.1 times base salary in stock. $56.65M of shares against $698.26K in salary for 2025.

Salary from the company's own proxy. The shares are what Chad Robins last reported holding, valued at $25.98, the price Common Stock was last bought or sold at on the open market here, on 3 Nov 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Julie Rubinstein

President and COO

—

$6.47M (36) scheduled

−$6.47M

377,802

0.2367%

$9.82M

−20.1%

Susan Bobulsky

Chief Commercial Officer, MRD

—

$193.32K (1) scheduled

−$193.32K

389,350

0.2440%

$10.12M

+53.7%

Chad M Robins

CEO and Chairman

—

2,180,518

1.37%

$56.65M

−15.4%

Harlan S Robins

Chief Scientific Officer

—

812,058

0.5088%

$21.10M

−20.5%

Kyle Piskel

Chief Financial Officer

—

256,725

0.1609%

$6.67M

+74.9%

Francis Lo

Chief People Officer

—

223,367

0.1400%

$5.80M

−12.8%

Sharon Benzeno

Chief Commercial Ofc Imm Med

—

221,278

0.1386%

$5.75M

−32.4%

Peter M Neupert

Director

—

130,625

0.0818%

$3.39M

−22.8%

Michael J Pellini

Director

—

69,690

0.0437%

$1.81M

+28.4%

Katey Einterz Owen

Director

—

66,100

0.0414%

$1.72M

+15.5%

Robert Hershberg

Director

—

46,683

0.0293%

$1.21M

−56.5%

Michelle Renee Griffin

Director

—

15,625

0.0098%

$405.94K

−69.9%

Adaptive Biotechnologies Corp

What the insiders did Scheduled selling only

By person